H1661B2091A04198 AJB:CDM 04/29/24 #90 A04198
AMENDMENTS TO HOUSE BILL NO. 1661
Sponsor: SENATOR VOGEL
Printer's No. 2091
Amend Bill, page 1, lines 10 through 12, by striking out
"further providing for" in line 10 and all of lines 11 and 12
and inserting
further providing for schedules of controlled substances; and
providing for secure storage of xylazine.
Amend Bill, page 1, lines 15 through 22; pages 2 through 4,
lines 1 through 30; page 5, lines 1 through 14; by striking out
all of said lines on said pages and inserting
Section 1. Section 4(3) of the act of April 14, 1972
(P.L.233, No.64), known as The Controlled Substance, Drug,
Device and Cosmetic Act, is amended by adding subclauses to
read:
Section 4. Schedules of Controlled Substances.--The
following schedules include the controlled substances listed or
to be listed by whatever official name, common or usual name,
chemical name, or trade name designated.
* * *
(3) Schedule III--In determining that a substance comes
within this schedule, the secretary shall find: a potential for
abuse less than the substances listed in Schedules I and II;
well documented and currently accepted medical use in the United
States; and abuse may lead to moderate or low physical
dependence or high psychological dependence. The following
classes of controlled substances are included in this schedule:
* * *
(x) Xylazine, including any of the following substances,
their salts, isomers and salts of isomers whenever the existence
of the salts, isomers and salts of isomers is possible within
the specific chemical designation:
1. Xylazine.
2. Xylazine-M (2,6Mich dimethylaniline).
3. Xylazine-M (N-thiourea-2,6-dimethylaniline).
4. Xylazine-M (Sulfone-HO-) isomer 2.
5. Xylazine-M (HO-2,6-dimethylaline isomer 1).
2024/90AJB/HB1661A04198 - 1 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
6. Xylazine-M (HO-2,6-dimethylaline isomer 2).
7. Xylazine M (oxo-).
8. Xylazine-M (HO-) isomer 1.
9. Xylazine-M (HO-) isomer 1 glucuronide.
10. Xylazine-M (HO-) isomer 2.
11. Xylazine-M (HO-) isomer 2 glucuronide.
12. Xylazine-M (HO-oxo-) isomer 1.
13. Xylazine-M (HO-oxo-) isomer 1 glucuronide.
14. Xylazine-M (HO-oxo-) isomer 2.
15. Xylazine-M (HO-oxo-) isomer 2 glucuronide.
16. Xylazine-M (sulfone).
17. Xylazine-M (sulfone-HO-) isomer 1.
18. A compound, mixture or preparation which contains any
quantity of the substances referred to in this clause.
(xi) Xylazine as described in subclause (x) is not a
controlled substance when used in any of the following manners:
1. Dispensing or prescribing for, or administering to, a
nonhuman species of a drug containing xylazine that:
(A) has been approved by the United States Secretary of
Health and Human Services under 21 U.S.C. § 360b (relating to
new animal drugs); or
(B) is authorized under 21 U.S.C. § 360b(a)(4).
2. The manufacturing, distribution or use of xylazine as an
active pharmaceutical ingredient for manufacturing an animal
drug approved under 21 U.S.C. § 360b or an animal drug that has
been issued an investigation use exemption under 21 U.S.C. §
360b(j).
3. The manufacturing, distribution or use of a xylazine bulk
chemical for pharmaceutical compounding by a licensed pharmacist
or veterinarians.
4. Any other use approved or authorized under 21 U.S.C. Ch.
9 (relating to Federal Food, Drug, and Cosmetic Act).
5. Another use approved or permissible under Federal or
State law.
* * *
Amend Bill, page 5, line 15, by striking out "3" and
inserting
2
Amend Bill, page 5, line 21, by striking out all of said line
and inserting
Section 3. This act shall take effect immediately.
2024/90AJB/HB1661A04198 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41